Submitted Successfully!
To reward your contribution, here is a gift for you: A free trial for our video production service.
Thank you for your contribution! You can also upload a video entry or images related to this topic.
Version Summary Created by Modification Content Size Created at Operation
1
Hubertus Himmerich
 + 1593 word(s) 1593 2021-04-22 05:24:35 |
2 format correct
Dean Liu
 -10 word(s) 1583 2021-05-12 11:13:06 |

Video Upload Options

We provide professional Video Production Services to translate complex research into visually appealing presentations. Would you like to try it?
No, upload directly Yes

Confirm

Are you sure to Delete?
Yes No
Cite
If you have any further questions, please contact Encyclopedia Editorial Office.
Himmerich, H. Diet, Obesity, and Depression. Encyclopedia. Available online: https://encyclopedia.pub/entry/9556 (accessed on 19 November 2024).
Himmerich H. Diet, Obesity, and Depression. Encyclopedia. Available at: https://encyclopedia.pub/entry/9556. Accessed November 19, 2024.
Himmerich, Hubertus. "Diet, Obesity, and Depression" Encyclopedia, https://encyclopedia.pub/entry/9556 (accessed November 19, 2024).
Himmerich, H. (2021, May 12). Diet, Obesity, and Depression. In Encyclopedia. https://encyclopedia.pub/entry/9556
Himmerich, Hubertus. "Diet, Obesity, and Depression." Encyclopedia. Web. 12 May, 2021.
Diet, Obesity, and Depression
Edit
This entry is adapted from the peer-reviewed paper 10.3390/jpm11030176

Obesity and depression co-occur in a significant proportion of the population. Mechanisms linking the two disorders include the immune and the endocrine system, psychological and social mechanisms. 

obesity depression diet systematic review weight loss

1. Introduction

Both depression and obesity are major public health concerns [1][2] with high worldwide prevalence and associated increased cardiovascular risks [3][4]. Research has revealed an association between depression and obesity, with the prevalence of depression in obese individuals being twice as high as in those of normal weight [5]. The relationship between depression and obesity, although established and confirmed by numerous epidemiological studies and meta-analyses, has not yet been fully clarified. The association has been repeatedly examined with some authors asserting that depression results in weight gain and obesity and others claiming that obesity leads to depression, implying a bidirectional causality [6]. It has been suggested that both depression and obesity are due to dysregulation of stress responses, principally involving the hypothalamic–pituitary–adrenal (HPA) axis [7]. Additional mechanisms linking the two disorders are inflammation, oxidative stress, and other endocrine dysfunctions [8], as well as psychological mechanisms such as rumination, stigmatization and ostracism that contribute to and maintain the bidirectional relationship [9][10].

2. Diet and Depression

The typical diets of western societies have high amounts of saturated fats and refined sugars, as well as high amounts of red and processed meats, with concurrent low levels of fruit, vegetable and fiber intake. This results in a diet that is energy-dense and nutrient-poor with profound consequences for both our physical and mental health. The relationship between diet and obesity is clear; individuals consuming more calories than the recommended daily allowance, combined with consuming high amounts of foods high in fat and sugar content, are more likely to develop obesity. More recently, the impact of diet on mental health has also been revealed to be significant; for example, a recent meta-analysis found that adults following a healthy dietary pattern have fewer depressive symptoms and lower risk of developing depressive symptoms [11].

The precise etiology of depression is unknown, but many psychological, social, and biological underpinnings are thought to contribute to its development [12]. The latter includes genetic, hormonal, immunological, biochemical, and neurodegenerative factors. Concurrently, research has shown that these physiological aspects can be modulated by diet and nutrition. For example, in the case of genes, vitamin E has been shown to modulate several genes involved in neural signal transduction, inflammation and cell proliferation among others, while omega-3 polyunsaturated fatty acids (n-3 PUFAs) [13] have been shown to interact with genes that code for cytokines, cholesterol metabolizing enzymes, and growth factors [14].

3. Depression and Obesity

Many authors posit that depression is a heterogenous assortment of symptoms that can be divided into subtypes based on the accompanying presenting symptoms beyond low mood. Most recently, it has been subdivided into two main subtypes: type 1, which is characterized by loss of appetite and body weight, insomnia, and suicidal ideation, and type 2, also known as atypical depression, which presents with increased appetite and weight gain, leaden paralysis, hypersomnia, and a persistently poor metabolic profile [15]. Several factors are thought to moderate the relationship between obesity and depression. Stunkard et al. have reviewed the literature pertaining to what those moderators and mediators could be, and they have identified several including the severity of obesity, the severity of depression, and stress [16].

Correlations between both disorders involve disturbance of appetite regulation, changes in metabolic, hormonal and immunological parameters, and behavioral problems such as reduced physical activity [9][10][17][18][19][20]. More specifically, obesity has been shown to induce important physical, psychological, and behavioral changes in vulnerable patients, such as changes in the hormone and cytokine systems [18][21], changes in thought processes such as rumination [9], and behavioral changes such as reduced physical activity [20]. These changes are known risk factors of depression [17][20]. Thus, in obese patients, depression can be seen as a health consequence of obesity. If obesity contributes to the development and maintenance of depression, we can hypothesize that weight loss might help those depressed patients who are obese. Indeed, recent studies indicate that weight loss due to caloric restriction or gastric bypass surgery improves depressive symptoms among obese patients with depression [22][23][24][25]. Therefore, we sought to review and collate the existing research literature on the effects of diet modifications on depressive symptoms in overweight or obese individuals enrolled in dietary weight loss programs. The underlying idea was that in people with obesity and depression, depression occurs as a consequence of obesity, and therefore weight loss could not only help with regard to obesity but could also reduce depressive symptoms.

4. Possible Mechanisms for Improved Mood after Weight Loss

It is well established that depression and obesity co-occur to a high degree [5][6][26][27][28][29], however the relationship between the two disorders is complex and currently of ambiguous directionality. Stunkard et al. presented a summary on the existing data using a moderator/mediator framework in which they classified eating and physical activity as an important mediator of obesity and comorbid depression [16]. Some authors consider depression as a consequence of obesity resulting from societal stigmatization, dissatisfaction with one’s appearance, and low self-esteem [30][31][32]. Others consider obesity as resulting from decreased physical activity, excessive ‘comfort’ eating, and antidepressant medication use that often accompanies depression [33][34][35][36][37].

Several epidemiological studies have found associations between mood and diet. Particularly, a western-style diet high in processed foods and sugar content and low in fruits and vegetables, is associated with worsening of mood states. Indeed, one of our included studies found increases in depression scores in participants on a high glycemic load diet [38]. Diets that are high in carbohydrates but low in fat and protein have also been associated with lower mood scores in cross-sectional studies [39][40], whereas an abundance of research extols the beneficial effects of Mediterranean-style diets [41] which are high in fruit, vegetables, nuts, pulses and wholegrains, low in fat and carbohydrate, with very little processed foods. The differences in mood scores between these two types of diets are thought to be partly due to the increased systemic inflammation and oxidative processes that often accompanies a western-style diet [42][43][44][45].

4.1. Physiological Mechanisms

Research has exposed metabolic and inflammatory dysregulation as a common denominator in depression and obesity [46][47]. Additionally, both depressed and obese patients exhibit dysregulation of the hypothalamic–pituitary–adrenal (HPA) axis [48][49] and consequently chronic elevations in cortisol [50][51]. Increases in cortisol levels have been reported as having a causal role in depression, as well as leading to weight gain, specifically in abdominal adiposity. Recently, white adipose tissue (WAT) has been conceptualized as an endocrine organ, as opposed to how it was previously thought of—as an inert storage tissue—due to its ability to produce cytokines and other related molecules. Among these are interleukin (IL)-1β, IL-6, and tumor necrosis factor (TNF)-α [52][53][54], which are known proinflammatory cytokines, as well as chemokines, including monocyte chemoattractant protein (MCP)-1 [55][56]. The ensuing signaling cascade leads to immune activation and white blood cell accumulation, and an overall increased inflammatory response. This immune activation has various downstream effects. For example, IL-2 reduces tryptophan plasma levels [57], possibly by activating tryptophan 2,3-dioxygenase (TDO) and indoleamine 2,3-dioxygenase (IDO). Tryptophan is an essential amino acid necessary for 5-HT synthesis. Low levels of tryptophan could lead to lower levels of serotonin and thus affect mood. Another example is the accumulation of peripheral monocytes in the brain as a result of systemic inflammation [58], and specifically the increased production of MCP-1 in hypothalamic neurons. This monocyte migration has been associated with increased anxiety and depression [59]. Minimization of accumulated adipose tissue through weight loss could attenuate this inflammatory process, leading to improved mood.

Another molecule implicated in both obesity and depression is leptin. Leptin is a peptide hormone released by adipocytes and crosses the blood–brain barrier via a saturable transport mechanism. Low plasma levels of leptin have been observed in depressed patients [60][61]. In the case of obesity however, plasma leptin levels have been found to be elevated [62][63]. This contradictory finding can be explained by leptin resistance (as in the case of type 2 diabetic patients being resistant to insulin) and could be a result of impaired transport across the blood–brain barrier, of reduced function of the leptin receptor, or errors in signal transduction [64][65]. Similar to cortisol and inflammatory molecules described previously, leptin modulates HPA axis function [66][67]. Leptin also interacts with monoamines and although its effect on monoamine neurotransmission remains unclear, there is evidence for leptin’s involvement in the 5-HT system [68] and in the activation of STAT3 in dopamine neurons of the ventral tegmental area (VTA) [69]. Reducing the amount of adipose tissue through diet and subsequent weight loss could ameliorate leptin resistance, reinstate leptin function, and relieve low mood.

4.2. Psychosocial Mechanisms

It should be borne in mind that psychosocial attributes may affect physiology, and the distinction between the two mechanisms here is for ease of discussion. A good example of this environment x biology interaction is the finding that weight discrimination, often experienced by obese individuals, increases cortisol levels [70]. Additionally, repeated discrimination can lead to lower self-esteem and increased negative affect [71]. Many studies have reported on the negative attitudes of employers, peers, and even clinicians towards obese persons [72][73]. Continued maltreatment can impact obese persons’ mood and self-concept, both of which can contribute to depression.

Even if obese individuals do not experience weight discrimination or stigma by others, their self-esteem could be impacted by their own body image dissatisfaction (BID). Some research has found correlations between BID and depressive symptoms and suggested that obesity confers risk for developing depression through increased BID [74][75]. Therefore, it is possible that losing weight improves body image satisfaction and low mood. For a more thorough discussion see Markowitz et al. [76].

References

  1. Agha, M.; Agha, R. The rising prevalence of obesity. Int. J. Surg. Oncol. 2017, 2, e17.
  2. Liu, Q.; He, H.; Yang, J.; Feng, X.; Zhao, F.; Lyu, J. Changes in the global burden of depression from 1990 to 2017: Findings from the Global Burden of Disease study. J. Psychiatr. Res. 2020, 126, 134–140.
  3. Kotsis, V.; Tsioufis, K.; Antza, C.; Seravalle, G.; Coca, A.; Sierra, C.; Lurbe, E.; Stabouli, S.; Jelakovic, B.; Redon, J.; et al. Obesity and cardiovascular risk: A call for action from the European Society of Hypertension Working Group of Obesity, Diabetes and the High-risk Patient and European Association for the Study of Obesity: Part B: Obesity-induced cardiovascular disease, early prevention strategies and future research directions. J. Hypertens. 2018, 36, 1441–1455.
  4. Penninx, B.W.J.H.; Beekman, A.T.F.; Honig, A.; Deeg, D.J.H.; Schoevers, R.A.; Van Eijk, J.T.M.; van Tilburg, W. Depression and cardiac mortality: Results from a community-based longitudinal study. Arch. Gen. Psychiatry 2001, 58, 221–227.
  5. Pereira-Miranda, E.; Costa, P.R.F.; Queiroz, V.A.O.; Pereira-Santos, M.; Santana, M.L.P. Overweight and Obesity Associated with Higher Depression Prevalence in Adults: A Systematic Review and Meta-Analysis. J. Am. Coll. Nutr. 2017, 36, 223–233.
  6. Luppino, F.S.; de Wit, L.M.; Bouvy, P.F.; Stijnen, T.; Cuijpers, P.; Penninx, B.W.J.H.; Zitman, F.G. Overweight, Obesity, and Depression. Arch. Gen. Psychiatry 2010, 67, 220.
  7. Bornstein, S.R.; Schuppenies, A.; Wong, M.L.; Licinio, J. Approaching the shared biology of obesity and depression: The stress axis as the locus of gene-environment interactions. Mol. Psychiatry 2006, 11, 892–902.
  8. Hryhorczuk, C.; Sharma, S. Metabolic disturbances connecting obesity and depression. Front. Neurosci. 2013, 7, 177.
  9. Minkwitz, J.; Scheipl, F.; Cartwright, L.; Campbell, I.C.; Chittka, T.; Thormann, J.; Hegerl, U.; Sander, C.; Himmerich, H. Why some obese people become depressed whilst others do not: Exploring links between cognitive reactivity, depression and obesity. Psychol. Health Med. 2019, 24, 362–373.
  10. Thormann, J.; Chittka, T.; Minkwitz, J.; Kluge, M.; Himmerich, H. Obesity and depression: An overview on the complex interactions of two diseases. Fortschr. Neurol. Psychiatr. 2013, 81, 145–153.
  11. Nicolaou, M.; Colpo, M.; Vermeulen, E.; Elstgeest, L.E.M.; Cabout, M.; Gibson-Smith, D.; Knuppel, A.; Sini, G.; Schoenaker, D.A.J.M.; Mishra, G.D.; et al. Association of a priori dietary patterns with depressive symptoms: A harmonised meta-analysis of observational studies. Psychol. Med. 2020, 50, 1872–1883.
  12. Himmerich, H.; Kohls, E.; Hegerl, U.; Rummel-Kluge, C. Predictive factors of depression and its therapy. Nervenarzt 2014, 85, 1249–1254.
  13. Azzi, A.; Gysin, R.; Kempná, P.; Munteanu, A.; Villacorta, L.; Visarius, T.; Zingg, J.M. Regulation of gene expression by α-tocopherol. Biol. Chem. 2004, 385, 585–591.
  14. Kornman, K.S.; Martha, P.M.; Duff, G.W. Genetic variations and inflammation: A practical nutrigenomics opportunity. Nutrition 2004, 20, 44–49.
  15. Lamers, F.; Beekman, A.T.F.; Van Hemert, A.M.; Schoevers, R.A.; Penninx, B.W.J.H. Six-year longitudinal course and outcomes of subtypes of depression. Br. J. Psychiatry 2016, 208, 62–68.
  16. Stunkard, A.J.; Faith, M.S.; Allison, K.C. Depression and obesity. Biol. Psychiatry 2003, 54, 330–337.
  17. Schmidt, F.M.; Lichtblau, N.; Minkwitz, J.; Chittka, T.; Thormann, J.; Kirkby, K.C.; Sander, C.; Mergl, R.; Faßhauer, M.; Stumvoll, M.; et al. Cytokine levels in depressed and non-depressed subjects, and masking effects of obesity. J. Psychiatr. Res. 2014, 55, 29–34.
  18. Schmidt, F.M.; Weschenfelder, J.; Sander, C.; Minkwitz, J.; Thormann, J.; Chittka, T.; Mergl, R.; Kirkby, K.C.; Faßhauer, M.; Stumvoll, M.; et al. Inflammatory Cytokines in General and Central Obesity and Modulating Effects of Physical Activity. PLoS ONE 2015, 10, e0121971.
  19. Schmidt, F.M.; Mergl, R.; Minkwitz, J.; Holdt, L.M.; Teupser, D.; Hegerl, U.; Himmerich, H.; Sander, C. Is There an Association or Not?—Investigating the Association of Depressiveness, Physical Activity, Body Composition and Sleep with Mediators of Inflammation. Front. Psychiatry 2020, 11, 563.
  20. Sander, C.; Ueck, P.; Mergl, R.; Gordon, G.; Hegerl, U.; Himmerich, H. Physical activity in depressed and non-depressed patients with obesity. Eat. Weight Disord. 2018, 23, 195–203.
  21. Zorena, K.; Jachimowicz-Duda, O.; Ślęzak, D.; Robakowska, M.; Mrugacz, M. Adipokines and Obesity. Potential Link to Metabolic Disorders and Chronic Complications. Int. J. Mol. Sci. 2020, 21, 3570.
  22. Waters, G.S.; Pories, W.J.; Swanson, M.S.; Meelheim, H.D.; Flickinger, E.G.; May, H.J. Long-term studies of mental health after the greenville gastric bypass operation for morbid obesity. Am. J. Surg. 1991, 161, 154–158.
  23. Dymek, M.P.; Le Grange, D.; Neven, K.; Alverdy, J. Quality of life and psychosocial adjustment in patients after Roux-en-Y gastric Bypass: A brief report. Obes. Surg. 2001, 11, 32–39.
  24. Emery, C.F.; Fondow, M.D.M.; Schneider, C.M.; Christofi, F.L.; Hunt, C.; Busby, A.K.; Needleman, B.J.; Melvin, W.S.; Elsayed-Awad, H.M. Gastric bypass surgery is associated with reduced inflammation and less depression: A preliminary investigation. Obes. Surg. 2007, 17, 759–763.
  25. Vaghef-Mehrabany, E.; Ranjbar, F.; Asghari-Jafarabadi, M.; Hosseinpour-Arjmand, S. Calorie restriction in combination with prebiotic supplementation in obese women with depression: Effects on metabolic and clinical response. Nutr. Neurosci. 2019, 25, 1–15.
  26. Carey, M.; Small, H.; Yoong, S.L.; Boyes, A.; Bisquera, A.; Sanson-Fisher, R. Prevalence of comorbid depression and obesity in general practice: A cross-sectional survey. Br. J. Gen. Pract. 2014, 64, e122.
  27. Levitan, R.D.; Davis, C.; Kaplan, A.S.; Arenovich, T.; Phillips, D.I.W.; Ravindran, A.V. Obesity Comorbidity in Unipolar Major Depressive Disorder. J. Clin. Psychiatry 2012, 73, 1119–1124.
  28. Wadden, T.A.; Steen, S.N.; Wingate, B.J.; Foster, G.D. Psychosocial consequences of weight reduction: How much weight loss is enough? Am. J. Clin. Nutr. 1996, 63 (Suppl. 3), 461–465.
  29. Quinn, D.M.; Puhl, R.M.; Reinka, M.A. Trying again (and again): Weight cycling and depressive symptoms in U.S. adults. PLoS ONE 2020, 15, e0239004.
  30. Brownell, K.D.; Puhl, R.M.; Schwartz, M.B.; Rudd, L. Weight Bias: Nature, Consequences, and Remedies; Guilford Publications: New York, NY, USA, 2005.
  31. Kasen, S.; Cohen, P.; Chen, H.; Must, A. Obesity and psychopathology in women: A three decade prospective study. Int. J. Obes. 2008, 32, 558–566.
  32. Roberts, R.; Deleger, S.; Strawbridge, W.J.; Kaplan, G.A. Prospective association between obesity and depression: Evidence from the Alameda County Study. Int. J. Obes. 2003, 27, 514–521.
  33. Wise, L.A.; Adams-Campbell, L.L.; Palmer, J.R.; Rosenberg, L. Leisure time physical activity in relation to depressive symptoms in the Black Women’s Health Study. Ann. Behav. Med. 2006, 32, 68–76.
  34. Oliver, G.; Wardle, J. Perceived effects of stress on food choice. Physiol. Behav. 1999, 66, 511–515.
  35. Dallman, M.F.; Pecoraro, N.C.; La Fleur, S.E. Chronic stress and comfort foods: Self-medication and abdominal obesity. Brain Behav. Immun. 2005, 19, 275–280.
  36. Himmerich, H.; Minkwitz, J.; Kirkby, K.C. Weight Gain and Metabolic Changes During Treatment with Antipsychotics and Antidepressants. Endocr. Metab. Immune Disord. Drug Targets 2015, 15, 252–260.
  37. Serretti, A.; Mandelli, L. Antidepressants and Body Weight. J. Clin. Psychiatry 2010, 71, 1259–1272.
  38. Breymeyer, K.L.; Lampe, J.W.; McGregor, B.A.; Neuhouser, M.L. Subjective mood and energy levels of healthy weight and overweight/obese healthy adults on high-and low-glycemic load experimental diets. Appetite 2016, 107, 253–359.
  39. Pellegrin, K.L.; O’Neil, P.M.; Stellefson, E.J.; Fossey, M.D.; Ballenger, J.C.; Cochrane, C.E.; Currey, H.S. Average daily nutrient intake and mood among obese women. Nutr. Res. 1998, 18, 1103–1112.
  40. de Castro, J.M. Macronutrient relationships with meal patterns and mood in the spontaneous feeding behavior of humans. Physiol. Behav. 1987, 39, 561–569.
  41. Muñoz, M.A.; Fíto, M.; Marrugat, J.; Covas, M.I.; Schröder, H. Adherence to the Mediterranean diet is associated with better mental and physical health. Br. J. Nutr. 2009, 101, 1821–1827.
  42. Akbaraly, T.N.; Brunner, E.J.; Ferrie, J.E.; Marmot, M.G.; Kivimaki, M.; Singh-Manoux, A. Dietary pattern and depressive symptoms in middle age. Br. J. Psychiatry 2009, 195, 408–413.
  43. Jacka, F.N.; Pasco, J.A.; Mykletun, A.; Williams, L.J.; Hodge, A.M.; O’Reilly, S.L.; Nicholson, G.C.; Kotowicz, M.A.; Berk, M. Association of western and traditional diets with depression and anxiety in women. Am. J. Psychiatry 2010, 167, 305–311.
  44. Kiecolt-Glaser, J.K. Stress, food, and inflammation: Psychoneuroimmunology and nutrition at the cutting edge. Psychosom. Med. 2010, 72, 365–369.
  45. Shelton, R.C.; Miller, A.H. Eating ourselves to death (and despair): The contribution of adiposity and inflammation to depression. Prog. Neurobiol. 2010, 91, 275–299.
  46. Raison, C.; Miller, A. Is depression an inflammatory disorder? Curr. Psychiatry Rep. 2011, 13, 467–475.
  47. Milaneschi, Y.; Simmons, W.K.; van Rossum, E.F.C.; Penninx, B.W.J.H. Depression and obesity: Evidence of shared biological mechanisms. Mol. Psychiatry 2019, 24, 18–33.
  48. De Bellis, M.D.; Gold, P.W.; Geracioti, T.D.; Listwak, S.J.; Kling, M.A. Association of fluoxetine treatment with reductions in CSF concentrations of corticotropin-releasing hormone and arginine vasopressin in patients with major depression. Am. J. Psychiatry 1993, 150, 656–657.
  49. De Mello, A.F.; De Mello, M.F.; Carpenter, L.L.; Price, L.H. Update on stress and depression: The role of the hypothalamic-pituitary-adrenal (HPA) axis. Braz. J. Psychiatry 2003, 25, 231–238.
  50. Gibbons, J.L.; McHugh, P.R. Plasma cortisol in depressive illness. J. Psychiatr. Res. 1962, 1, 162–171.
  51. Sachar, E.J.; Hellman, L.; Fukushima, D.K.; Gallagher, T.F. Cortisol Production in Depressive Illness: A Clinical and Biochemical Clarification. Arch. Gen. Psychiatry 1970, 23, 289–298.
  52. Hotamisligil, G.S.; Shargill, N.S.; Spiegelman, B.M. Adipose expression of tumor necrosis factor-α: Direct role in obesity-linked insulin resistance. Science 1993, 259, 87–91.
  53. Ouchi, N.; Parker, J.L.; Lugus, J.J.; Walsh, K. Adipokines in inflammation and metabolic disease. Nat. Rev. Immunol. 2011, 11, 85–97.
  54. Makki, K.; Froguel, P.; Wolowczuk, I. Adipose Tissue in Obesity-Related Inflammation and Insulin Resistance: Cells, Cytokines, and Chemokines. ISRN Inflamm. 2013, 2013, 139239.
  55. Kanda, H.; Tateya, S.; Tamori, Y.; Kotani, K.; Hiasa, K.I.; Kitazawa, R.; Kitazawa, S.; Miyachi, H.; Maeda, S.; Egashira, K.; et al. MCP–1 contributes to macrophage infiltration into adipose tissue, insulin resistance, and hepatic steatosis in obesity. J. Clin. Investig. 2006, 116, 1494–1505.
  56. Kamei, N.; Tobe, K.; Suzuki, R.; Ohsugi, M.; Watanabe, T.; Kubota, N.; Ohtsuka-Kowatari, N.; Kumagai, K.; Sakamoto, K.; Kobayashi, M.; et al. Overexpression of monocyte chemoattractant protein-1 in adipose tissues causes macrophage recruitment and insulin resistance. J. Biol. Chem. 2006, 281, 26602–26614.
  57. Capuron, L.; Ravaud, A.; Neveu, P.J.; Miller, A.H.; Maes, M.; Dantzer, R. Association between decreased serum tryptophan concentrations and depressive symptoms in cancer patients undergoing cytokine therapy. Mol. Psychiatry 2002, 7, 468–473.
  58. Wohleb, E.S.; McKim, D.B.; Sheridan, J.F.; Godbout, J.P. Monocyte trafficking to the brain with stress and inflammation: A novel axis of immune-to-brain communication that influences mood and behavior. Front. Neurosci. 2015, 8, 447.
  59. Ataka, K.; Asakawa, A.; Nagaishi, K.; Kaimoto, K.; Sawada, A.; Sawada, A.; Hayakawa, Y.; Tatezawa, R.; Inui, A.; Fujimiya, M. Bone Marrow-Derived Microglia Infiltrate into the Paraventricular Nucleus of Chronic Psychological Stress-Loaded Mice. Harrison JK, editor. PLoS ONE 2013, 8, e81744.
  60. Kraus, T.; Haack, M.; Schuld, A.; Hinze-Selch, D.; Pollmächer, T. Low leptin levels but normal body mass indices in patients with depression or schizophrenia. Neuroendocrinology 2001, 73, 243–247.
  61. Jow, G.M.; Yang, T.T.; Chen, C.L. Leptin and cholesterol levels are low in major depressive disorder, but high in schizophrenia. J. Affect. Disord. 2006, 90, 21–27.
  62. Maffei, M.; Halaas, J.; Ravussin, E.; Pratley, R.; Lee, G.H.; Zhang, Y.; Fei, H.; Kim, S.; Lallone, R.; Ranganathan, S.; et al. Leptin levels in human and rodent: Measurement of plasma leptin and ob RNA in obese and weight-reduced subjects. Nat. Med. 1997, 1, 1155–1161.
  63. Silha, J.V.; Krsek, M.; Skrha, J.V.; Sucharda, P.; Nyomba, L.G.; Murphy, L.J. Plasma resistin, adiponectin and leptin levels in lean and obese subjects: Correlations with insulin resistance. Eur. J. Endocrinol. 2003, 149, 331–335.
  64. Münzberg, H.; Björnholm, M.; Bates, S.H.; Myers, M.G. Leptin receptor action and mechanisms of leptin resistance. Cell. Mol. Life Sci. 2005, 62, 642–652.
  65. Münzberg, H.; Myers, M.G. Molecular and anatomical determinants of central leptin resistance. Nat. Neurosci. 2005, 8, 566–570.
  66. Licinio, J.; Mantzoros, C.; Negrao, A.B.; Cizza, G.; Wong, M.L.; Bongiorno, P.B.; Chrousos, G.P.; Karp, B.; Allen, C.; Flier, J.S.; et al. Human leptin levels are pulsatile and inversely related to pituitary–ardenal function. Nat. Med. 1997, 3, 575–579.
  67. Chen, H.; Charlat, O.; Tartaglia, L.A.; Woolf, E.A.; Weng, X.; Ellis, S.J.; Lakey, N.D.; Culpepper, J.; Moore, K.J.; Breitbart, R.E.; et al. Evidence that the diabetes gene encodes the leptin receptor: Identification of a mutation in the leptin receptor gene in db/db mice. Cell 1996, 84, 491–495.
  68. Calapai, G.; Corica, F.; Corsonello, A.; Sautebin, L.; Di Rosa, M.; Campo, G.M.; Buemi, M.; Mauro, V.N.; Caputi, A.P. Leptin increases serotonin turnover by inhibition of brain nitric oxide synthesis. J. Clin. Investig. 1999, 104, 975–982.
  69. Fulton, S.; Pissios, P.; Manchon, R.P.; Stiles, L.; Frank, L.; Pothos, E.N.; Maratos-Flier, E.; Flier, J.S. Leptin Regulation of the Mesoaccumbens Dopamine Pathway. Neuron 2006, 51, 811–822.
  70. Jackson, S.E.; Kirschbaum, C.; Steptoe, A. Perceived weight discrimination and chronic biochemical stress: A population-based study using cortisol in scalp hair. Obesity 2016, 24, 2515–2521.
  71. Kessler, R.C.; Mickelson, K.D.; Williams, D.R. The prevalence, distribution, and mental health correlates of perceived discrimination in the United States. J. Health Soc. Behav. 1999, 40, 208–230.
  72. Carr, D.; Friedman, M.A. Is obesity stigmatizing? Body weight, perceived discrimination, and psychological well-being in the United States. J. Health. Soc. Behav. 2005, 46, 244–259.
  73. Schwartz, M.B.; Chambliss, H.O.N.; Brownell, K.D.; Blair, S.N.; Billington, C. Weight Bias among Health Professionals Specializing in Obesity. Obes. Res. 2003, 11, 1033–1039.
  74. Friedman, M.A.; Brownell, K.D. Psychological Correlates of Obesity: Moving to the Next Research Generation. Psychol. Bull. 1995, 117, 3–20.
  75. Friedman, K.E.; Reichmann, S.K.; Costanzo, P.R.; Musante, G.J. Body image partially mediates the relationship between obesity and psychological distress. Obes. Res. 2002, 10, 33–41.
  76. Markowitz, S.; Friedman, M.A.; Arent, S.M. Understanding the Relation Between Obesity and Depression: Causal Mechanisms and Implications for Treatment. Clin. Psychol. Sci. Pract. 2008, 15, 1–20.
More
© Text is available under the terms and conditions of the Creative Commons Attribution (CC BY) license; additional terms may apply. By using this site, you agree to the Terms and Conditions and Privacy Policy.
Upload a video for this entry
Information
Subjects: Pharmacology & Pharmacy
Contributor MDPI registered users' name will be linked to their SciProfiles pages. To register with us, please refer to https://encyclopedia.pub/register :
Hubertus Himmerich
View Times: 469
Revisions: 2 times (View History)
Update Date: 12 May 2021
Table of Contents
    1000/1000
    Hot Most Recent
    ScholarVision Creations
    Feedback